Manoj Kumar appointed MD, Vivek Anand CFO
FMCG firm GlaxoSmithKline Consumer Healthcare Ltd has posted a net profit ofRs. 583.6 crore for the 12-month period ended March 31, 2015.
Net sales for the period stood at Rs. 4,136.4 crore.
In a BSE filing, the company said that in the previous accounting period, its financial year comprised 15 months from January 1, 2013, to March 31, 2014, whereas the results of the year ended March 31, 2015, represent 12 months of the current year and, therefore, are not comparable.
The Board of Directors of the company also recommended a dividend at Rs. 55 per equity share of Rs. 10 each for the 12-month period ended March 31, 2015, the company said in a statement.
In a statement, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare, said: “We are one of the few companies in the FMCG sector to register strong growth every quarter”.
The company also announced appointment of Manoj Kumar as Managing Director & Area General Manager for India Sub-Continent.
He will take over from Zubair Ahmed, who has been elevated as Head of Asia Pacific, Middle East & Africa operations of GSK Consumer Healthcare, an official statement said.
The company also announced the appointment of Vivek Anand as Director, Finance, and Chief Financial Officer.
He succeeds Ramakrishnan Subramanian, who has been elevated as Vice-President Finance for Asia Pacific, Middle East & Africa operations.
Both Kumar and Anand have been appointed on the Board of GSK Consumer Healthcare Ltd. In their new roles, Kumar will report to Ahmed and Anand will report to Subramanian, the statement added. Business Line
